Invention Grant
US09532986B2 Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
有权
具有抗结核分枝杆菌活性的脂质体环丙沙星制剂
- Patent Title: Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
- Patent Title (中): 具有抗结核分枝杆菌活性的脂质体环丙沙星制剂
-
Application No.: US14675218Application Date: 2015-03-31
-
Publication No.: US09532986B2Publication Date: 2017-01-03
- Inventor: Igor Gonda , James Blanchard , David C. Cipolla , Luiz Eduardo Moreira Bermudez
- Applicant: ARADIGM CORPORATION , OREGON STATE UNIVERSITY
- Applicant Address: US CA Hayward US OR Corvallis
- Assignee: ARADIGM CORPORATION,OREGON STATE UNIVERSITY
- Current Assignee: ARADIGM CORPORATION,OREGON STATE UNIVERSITY
- Current Assignee Address: US CA Hayward US OR Corvallis
- Agency: Bozicevic, Field and Francis LLP
- Agent Karl Bozicevic
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K31/496 ; A61K9/00
Abstract:
Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
Public/Granted literature
- US20150283133A1 LIPOSOMAL CIPROFLOXACIN FORMULATIONS WITH ACTIVITY AGAINST NON-TUBERCULOUS MYCOBACTERIA Public/Granted day:2015-10-08
Information query
